Market Closed -
Nyse
21:00:01 26/04/2024 BST
|
5-day change
|
1st Jan Change
|
166.1
USD
|
+0.58%
|
|
+5.46%
|
+8.93%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
12,564
|
11,684
|
10,421
|
10,060
|
10,405
|
11,182
|
-
|
-
|
Enterprise Value (EV)
1 |
16,487
|
14,316
|
14,496
|
14,766
|
15,198
|
15,669
|
15,808
|
15,473
|
P/E ratio
|
15.7
x
|
12.5
x
|
11
x
|
15.4
x
|
14.9
x
|
12
x
|
11.1
x
|
9.66
x
|
Yield
|
0.42%
|
0.15%
|
0.62%
|
0.57%
|
0.52%
|
0.49%
|
0.49%
|
0.5%
|
Capitalization / Revenue
|
1.1
x
|
1.01
x
|
0.82
x
|
0.75
x
|
0.73
x
|
0.72
x
|
0.68
x
|
0.64
x
|
EV / Revenue
|
1.45
x
|
1.24
x
|
1.15
x
|
1.1
x
|
1.06
x
|
1.01
x
|
0.96
x
|
0.89
x
|
EV / EBITDA
|
9.15
x
|
7.66
x
|
7.64
x
|
8.99
x
|
8.72
x
|
7.76
x
|
7.51
x
|
6.85
x
|
EV / FCF
|
20.5
x
|
8.79
x
|
517
x
|
56.4
x
|
29
x
|
20.9
x
|
19.3
x
|
17.1
x
|
FCF Yield
|
4.88%
|
11.4%
|
0.19%
|
1.77%
|
3.45%
|
4.79%
|
5.19%
|
5.86%
|
Price to Book
|
2.28
x
|
1.85
x
|
1.76
x
|
1.68
x
|
1.74
x
|
1.7
x
|
1.52
x
|
1.36
x
|
Nbr of stocks (in thousands)
|
87,582
|
84,982
|
80,377
|
71,410
|
68,259
|
67,334
|
-
|
-
|
Reference price
2 |
143.5
|
137.5
|
129.7
|
140.9
|
152.4
|
166.1
|
166.1
|
166.1
|
Announcement Date
|
26/02/20
|
25/02/21
|
24/02/22
|
27/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
11,378
|
11,559
|
12,642
|
13,399
|
14,282
|
15,567
|
16,413
|
17,339
|
EBITDA
1 |
1,802
|
1,869
|
1,896
|
1,643
|
1,743
|
2,019
|
2,106
|
2,260
|
EBIT
1 |
1,325
|
1,358
|
1,363
|
1,004
|
1,175
|
1,419
|
1,476
|
1,614
|
Operating Margin
|
11.64%
|
11.75%
|
10.78%
|
7.49%
|
8.23%
|
9.11%
|
9%
|
9.31%
|
Earnings before Tax (EBT)
1 |
1,066
|
1,252
|
1,293
|
866.3
|
940.4
|
1,210
|
1,257
|
1,407
|
Net income
1 |
814.9
|
944
|
991.6
|
675.6
|
717.8
|
935.5
|
968.9
|
1,057
|
Net margin
|
7.16%
|
8.17%
|
7.84%
|
5.04%
|
5.03%
|
6.01%
|
5.9%
|
6.1%
|
EPS
2 |
9.130
|
10.99
|
11.82
|
9.140
|
10.23
|
13.89
|
14.98
|
17.18
|
Free Cash Flow
1 |
804.4
|
1,629
|
28.04
|
262
|
524.7
|
751
|
820
|
907
|
FCF margin
|
7.07%
|
14.09%
|
0.22%
|
1.96%
|
3.67%
|
4.82%
|
5%
|
5.23%
|
FCF Conversion (EBITDA)
|
44.63%
|
87.16%
|
1.48%
|
15.95%
|
30.1%
|
37.19%
|
38.94%
|
40.14%
|
FCF Conversion (Net income)
|
98.71%
|
172.56%
|
2.83%
|
38.78%
|
73.1%
|
80.28%
|
84.63%
|
85.77%
|
Dividend per Share
2 |
0.6000
|
0.2000
|
0.8000
|
0.8000
|
0.8000
|
0.8098
|
0.8172
|
0.8283
|
Announcement Date
|
26/02/20
|
25/02/21
|
24/02/22
|
27/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
3,156
|
3,275
|
3,293
|
3,323
|
3,336
|
3,447
|
3,468
|
3,548
|
3,563
|
3,704
|
3,844
|
3,864
|
3,883
|
4,004
|
4,027
|
EBITDA
1 |
442.6
|
447
|
376.6
|
377.3
|
415.7
|
467.3
|
420.3
|
423.9
|
411.1
|
476.7
|
529.8
|
486.7
|
476.3
|
529.3
|
544.3
|
EBIT
1 |
314.8
|
313.6
|
232.9
|
233.4
|
275.9
|
261.4
|
278.7
|
280.1
|
285.4
|
331.2
|
388.8
|
340.5
|
326.5
|
369.9
|
387.4
|
Operating Margin
|
9.97%
|
9.58%
|
7.07%
|
7.02%
|
8.27%
|
7.58%
|
8.04%
|
7.9%
|
8.01%
|
8.94%
|
10.11%
|
8.81%
|
8.41%
|
9.24%
|
9.62%
|
Earnings before Tax (EBT)
1 |
286.9
|
306.7
|
200
|
209.7
|
234.2
|
222.3
|
214.1
|
224.7
|
220.5
|
281.1
|
336.1
|
299.1
|
273.3
|
311
|
319.9
|
Net income
1 |
218.4
|
239.1
|
153.9
|
164.1
|
182.8
|
174.8
|
163.1
|
171.3
|
167
|
216.4
|
261.8
|
225.2
|
203.5
|
245
|
253.8
|
Net margin
|
6.92%
|
7.3%
|
4.67%
|
4.94%
|
5.48%
|
5.07%
|
4.7%
|
4.83%
|
4.69%
|
5.84%
|
6.81%
|
5.83%
|
5.24%
|
6.12%
|
6.3%
|
EPS
2 |
2.600
|
3.000
|
2.020
|
2.200
|
2.500
|
2.430
|
2.280
|
2.420
|
2.400
|
3.160
|
3.820
|
3.287
|
3.058
|
3.741
|
3.923
|
Dividend per Share
2 |
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.2005
|
0.2011
|
0.2021
|
Announcement Date
|
25/10/21
|
24/02/22
|
25/04/22
|
25/07/22
|
25/10/22
|
27/02/23
|
25/04/23
|
25/07/23
|
25/10/23
|
27/02/24
|
24/04/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
3,923
|
2,632
|
4,075
|
4,705
|
4,793
|
4,488
|
4,627
|
4,291
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.177
x
|
1.408
x
|
2.149
x
|
2.864
x
|
2.749
x
|
2.223
x
|
2.197
x
|
1.899
x
|
Free Cash Flow
1 |
804
|
1,629
|
28
|
262
|
525
|
751
|
820
|
907
|
ROE (net income / shareholders' equity)
|
16.4%
|
16%
|
16%
|
12.2%
|
11.9%
|
14.3%
|
14.2%
|
14.2%
|
ROA (Net income/ Total Assets)
|
7.78%
|
7.51%
|
7.46%
|
5.49%
|
5.23%
|
6.51%
|
6.62%
|
6.9%
|
Assets
1 |
10,477
|
12,573
|
13,284
|
12,299
|
13,731
|
14,370
|
14,646
|
15,317
|
Book Value Per Share
2 |
62.80
|
74.30
|
73.80
|
83.80
|
87.70
|
97.90
|
109.0
|
122.0
|
Cash Flow per Share
2 |
16.20
|
27.60
|
10.60
|
13.50
|
18.10
|
22.10
|
24.40
|
-
|
Capex
1 |
634
|
731
|
856
|
734
|
743
|
950
|
956
|
982
|
Capex / Sales
|
5.57%
|
6.33%
|
6.77%
|
5.48%
|
5.2%
|
6.1%
|
5.82%
|
5.66%
|
Announcement Date
|
26/02/20
|
25/02/21
|
24/02/22
|
27/02/23
|
27/02/24
|
-
|
-
|
-
|
Last Close Price
166.1
USD Average target price
189.6
USD Spread / Average Target +14.20% Consensus |
1st Jan change
|
Capi.
|
---|
| +8.93% | 11.18B | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -31.75% | 11.77B | | -1.42% | 11.72B | | +27.44% | 11.71B |
Other Healthcare Facilities & Services
|